Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

ClinicalTrials.gov ID: NCT05145413

Public ClinicalTrials.gov record NCT05145413. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 1:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequate response to their current atypical antipsychotic treatment. The primary objective of the study is to assess the efficacy of adjunctive KarXT (a fixed dose combination of xanomeline and trospium chloride twice daily \[BID\]) versus placebo in the treatment of subjects with inadequately controlled symptoms of schizophrenia as measured by the Positive and Negative Syndrome Scale (PANSS) Total Score.

Study identification

NCT ID
NCT05145413
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
396 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 12, 2021 (Actual)
Primary completion
Mar 19, 2025 (Actual)
Completion
Mar 19, 2025 (Actual)
Last update posted
May 5, 2026

2021 – 2025

United States locations

U.S. sites
79
U.S. states
23
U.S. cities
64
Facility City State ZIP Site status
IMA Clinical Research Phoenix Arizona 85012 —
Local Institution - 147 Phoenix Arizona 85012 —
Pillar Clinical Research, LLC Little Rock Arkansas 72204 —
Woodland International Research Group, LLC Little Rock Arkansas 72211 —
Advanced Research Center, Inc. Anaheim California 92805 —
CITrials - Bellflower Bellflower California 90706-7079 —
Synexus Clinical Research US, Inc. Cerritos California 90703 —
Clinical Innovations Inc. Costa Mesa California 92626 —
Proscience Research Group Culver City California 90230 —
CenExel Collaborative Neuroscience Research Garden Grove California 92845 —
Omega Clinical Trials La Habra California 90631 —
Sunwise Clinical Research, LLC. Lafayette California 94549 —
Synergy Clinical Research of Escondido Lemon Grove California 91945 —
Encino Hospital Medical Center Los Angeles California 91403 —
Excell Research, Inc. Oceanside California 92056 —
Neuropsychiatric Research Center of Orange County Orange California 92868 —
CNRI - Los Angeles, LLC Pico Rivera California 90660 —
CenExel Clinical Innovations, Inc. Riverside California 92506 —
Cnri-San Diego San Diego California 92123 —
Stanford University School of Medicine Stanford California 94305 —
CenExel Collaborative Neuroscience Research Torrance California 90504 —
Local Institution - 186 Coral Gables Florida 33134 —
Reliable Clinical Research LLC Hialeah Florida 33012 —
Galiz Research, LLC Hialeah Florida 33016-1814 —
Adaptive Clinical Research, Inc Lauderhill Florida 33319-4985 —
Behavioral Clinical Research , Inc Miami Florida 33016 —
Premier Clinical Research Institute, Inc. Miami Florida 33122 —
San Marcus Research Clinic, Inc. Miami Lakes Florida 33014 —
Assertive Research Center Miami Lakes Florida 33016 —
Envision Trials LLC Miami Springs Florida 33166 —
Local Institution - 124 Orange City Florida 32763 —
Pines Care Research Center, Inc. Pembroke Pines Florida 33024 —
Interventional Psychiatry of Tampa Bay Tampa Florida 33629 —
Grady Memorial Hospital Atlanta Georgia 30303 —
Synexus Clinical Research US, Inc. Atlanta Georgia 30328 —
Local Institution - 192 Atlanta Georgia 30331 —
Local Institution - 135 Augusta Georgia 30912 —
CenExel iResearch Atlanta Decatur Georgia 30030 —
Psych Atlanta, P.C. Marietta Georgia 30060 —
CenExel iResearch, LLC Savannah Georgia 31405 —
Northwestern University Chicago Illinois 60611 —
American Medical Research, Inc. Chicago Illinois 60612-2307 —
Uptown Research Institute, LLC Chicago Illinois 60640 —
Phoenix Medical Research, Inc. Prairie Village Kansas 66208 —
IMA Clinical Research Monroe Louisiana 71201-2986 —
CenExel Center for Behavioral Health Gaithersburg Maryland 20877 —
Local Institution - 158 Boston Massachusetts 02114 —
Local Institution - 187 Boston Massachusetts 02118 —
Local Institution - 185 Worcester Massachusetts 01655 —
Michigan Clinical Research Institute PC Ann Arbor Michigan 48105 —
Cherry Health Grand Rapids Michigan 49548-6927 —
Western Michigan University Homer Stryker M.D. School of Medicine Kalamazoo Michigan 49001 —
Local Institution - 129 St Louis Missouri 63128 —
Arch Clinical Trials LLC St Louis Missouri 63141 —
Omaha Insomnia and Psychiatric Services LLC Omaha Nebraska 68144 —
Altea Research Institute, Las Vegas Las Vegas Nevada 89102 —
CenExel Hassman Research Institute Berlin New Jersey 08009 —
Synexus Clinical Research US, Inc. New York New York 10017 —
Manhattan Psychiatric Center New York New York 10027 —
Manhattan Behavioral Medicine, PLLC New York New York 10036 —
Psychiatry and Alzheimer's Care of Rochester. PLLC Rochester New York 14623 —
Richmond Behavioral Associates ERG Clinical Research - New York PLLC Staten Island New York 10314 —
Clinical Trials of America - Psychiatry Hickory North Carolina 28601 —
University of Cincinnati Medical Center Cincinnati Ohio 45219 —
Local Institution - 168 Garfield Heights Ohio 44125 —
Insight Clinical Trials LLC Independence Ohio 44131 —
The Rivus Wellness & Research Institute Oklahoma City Oklahoma 73112 —
Prevention Science Institute Eugene Oregon 97403 —
Community Clinical Research, Inc. Austin Texas 78754 —
InSite Clinical Research; LLC DeSoto Texas 75115 —
JPS Health Network Fort Worth Texas 76104 —
Ben Taub Hospital Houston Texas 77030 —
Clinical Trial Network LLC Houston Texas 77074 —
University Hills Clinical Research - Irving Irving Texas 75062 —
Pillar Clinical Research, LLC Richardson Texas 75080 —
At Health Texas Richmond Texas 77407 —
Perceptive Pharma Research Richmond Texas 77407 —
Green Mountain Research Institute Rutland Vermont 05701 —
Northwest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05145413, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05145413 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →